Bluereg / Specific Services for France
The Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM) is responsible for assessing the benefits and risks associated with the use of health products throughout their life-cycle. ANSM assesses the safety, efficacy and quality of these products and must balance patient safety with access to novel therapies.Our experienced regulatory team remains up to date with the French regulatory landscape.
You can rely on the experience and expertise of our consultants for providing advice and efficient implementation of your ATU projects (nominative and cohort). We can assist you in the following: